Physician’s Briefing Weekly Coronavirus Roundup
Meniscal Implant May Ease Post-Partial Meniscectomy Pain
Greater improvements in KOOS Overall and KOOS Pain seen in patients receiving synthetic medial meniscus implant versus nonsurgical care
Almost Half of Patients Admitted With COVID-19 Have Complications
Likelihood of having complications higher for men than women and for those aged older than 60 years
Neutralizing Monoclonal Antibody Combo Treats Mild, Moderate COVID-19
For those at high risk, COVID-19-related hospitalization or death from any cause reduced with bamlanivimab/etesevimab versus placebo
Staff Size, COVID-19 Outcomes Linked at Skilled Nursing Facilities
Conventional measures of staff quality, including direct care staff-to-resident ratio did not predict COVID-19 cases, deaths
Outpatient Antibiotic Prescribing Down in VA System
Annual percent decrease for all outpatient antibiotic use averaged 3.9 percent; largest decrease seen in ciprofloxacin use at 12.6 percent
Restrictive Eating Disorders Up Among Teens During Pandemic
For first 12 months of pandemic, number of admissions at children's hospital more than double for same period in previous three years
No Benefit Seen From Adjuvant Celecoxib in ERBB2-Negative Breast Cancer
Disease-free survival did not improve with two years of celecoxib versus placebo in ERBB2-negative breast cancer
Adding Ipilimumab to Nivolumab No Better in Pretreated Squamous NSCLC
No difference in overall survival seen with nivolumab plus ipilimumab, nivolumab alone for advanced, chemotherapy-pretreated disease
High-Dose Buprenorphine Induction in ED Seems Safe for Treating OUD
High-dose buprenorphine protocol well tolerated in patients with untreated opioid use disorder; no reports of respiratory depression or sedation
